GBS Inc. Reports Third Quarter 2022 Financial Results and :

- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University...

Related Keywords

United States , American , Steven Boyages , Biosensor Algorithm Development , Department Of Pathology , University Of Newcastle , Quest Diagnostics , Clinical Development , Nasdaq , Cash Equivalents , Marketable Securities , Institutional Review Board , Chief Executive Officer , Johns Hopkins Hospital , Status Updates , Specimen Collection Methodology , Support Subsequent Correlation , Oral Fluids , Venous Blood , Algorithm Development , North American , Webcast Registration , Nasdaq Gbs , Gbs Inc ,